Abstract
The authors present a man with Huntington disease who was treated with levetiracetam (Keppra) in an effort to reduce chorea. Chorea was markedly reduced, but the patient developed parkinsonism and lethargy after 6 weeks of treatment. Symptoms consisted of resting tremor, rigidity, increased dystonia, and gait difficulty. Side effects from levetiracetam resolved completely within 7 days of levetiracetam discontinuation, and chorea returned to baseline.
Original language | American English |
---|---|
Journal | Clinical Neuropharmacol |
Volume | 28 |
DOIs | |
State | Published - Jul 28 2005 |
Disciplines
- Public Health
Keywords
- Huntington Disease
- Levetiracetam-Induced Parkinsonism
- Patient